Kunpeng Project
ZWSOFT, Tianyang Technology, Xintian Pharmaceutical and other companies released important news
ZW: Net profit in fiscal year 2023 is 6225500,000, an increase of 887 year-on-year9%】
ZWTECH released its 2023 annual performance forecast, and the company completed 8Sales of 2.4 billion yuan increased by 37 percent over the same period last year18%；The net profit of the stock to shareholders of the parent company was 6,22550, an increase of 887 over the same period last year90%。
Tianyang Group: Haohong Group will sign a contract with Zhongtai Investment Group to transfer 20.3 million shares held by it by agreement
Tianyang Company announced that Ouyang Jianping, the controlling shareholder and actual controller of the company, and its affiliates ("Haohong Zhiye" or "Transferor") Lianyungang Haohong Zhiye Venture Capital** (hereinafter referred to as the "Transferor") proposed to transfer 20.3 million shares to Zhongtai** (Zhongtai**).
Chuanheng Group: Won the title of scientific and technological innovation enterprise].
Chuanheng Group announced that the company recently received the "High-tech Enterprise Certificate" (certificate number: GR202352000060) jointly awarded by the Guizhou Provincial Department of Science and Technology, the Guizhou Provincial Department of Finance and the Guizhou Provincial State Administration of Taxation, which is issued on December 12, 2022 and is valid for 3 years.
Xintian Pharmaceutical: Shuofang Pharmaceutical has been certified as a national high-tech enterprise. 》
Xintian Pharmaceutical announced that Shanghai Shuofang Pharmaceutical Technology Co., Ltd. has recently obtained the "High-tech Enterprise Certificate" jointly awarded by the Shanghai Municipal Science and Technology Commission, the Shanghai Municipal Finance Bureau and the Shanghai Municipal Administration of Taxation, and the company has obtained the national high-tech enterprise certification.
This article is compiled from public data and is not intended as a basis for advice or trading.